<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Laboratory | Hematology</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="Overview of the Testing Process In clinical laboratories, the testing process is generally divided into three phases: Pre-Analytical Phase: Includes all steps that occur before the actual testing...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="Laboratory | Hematology">
<meta property="og:type" content="book">
<meta property="og:description" content="Overview of the Testing Process In clinical laboratories, the testing process is generally divided into three phases: Pre-Analytical Phase: Includes all steps that occur before the actual testing...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Laboratory | Hematology">
<meta name="twitter:description" content="Overview of the Testing Process In clinical laboratories, the testing process is generally divided into three phases: Pre-Analytical Phase: Includes all steps that occur before the actual testing...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Hematology</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="content-areas.html">Content Areas</a></li>
<li><a class="" href="author.html">Author</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Erythrocytes</li>
<li><a class="" href="rbc-production.html">RBC Production</a></li>
<li><a class="" href="rbc-function.html">RBC Function</a></li>
<li><a class="" href="rbc-destruction.html">RBC Destruction</a></li>
<li><a class="" href="anemais.html">Anemais</a></li>
<li><a class="" href="microcytic.html">Microcytic</a></li>
<li><a class="" href="iron-deficiency.html">Iron Deficiency</a></li>
<li><a class="" href="chronic-disease.html">Chronic Disease</a></li>
<li><a class="" href="thalassemias.html">Thalassemias</a></li>
<li><a class="" href="sideroblastic.html">Sideroblastic</a></li>
<li><a class="" href="porphyria.html">Porphyria</a></li>
<li><a class="" href="normocytic.html">Normocytic</a></li>
<li><a class="" href="hereditary-hemolytic.html">Hereditary Hemolytic</a></li>
<li><a class="" href="acquired-hemolytic.html">Acquired Hemolytic</a></li>
<li><a class="" href="hypoproliferative.html">Hypoproliferative</a></li>
<li><a class="" href="acute-hemorrhage.html">Acute Hemorrhage</a></li>
<li><a class="" href="macrocytic.html">Macrocytic</a></li>
<li><a class="" href="megaloblastic.html">Megaloblastic</a></li>
<li><a class="" href="nonmegaloblastic.html">Nonmegaloblastic</a></li>
<li><a class="" href="hemoglobinopathies.html">Hemoglobinopathies</a></li>
<li><a class="" href="erythrocytosis.html">Erythrocytosis</a></li>
<li class="book-part">Leukocytes</li>
<li><a class="" href="wbc-production.html">WBC Production</a></li>
<li><a class="" href="wbc-function.html">WBC Function</a></li>
<li><a class="" href="wbc-destruction.html">WBC Destruction</a></li>
<li><a class="" href="benign-disorders.html">Benign Disorders</a></li>
<li><a class="" href="myeloid.html">Myeloid</a></li>
<li><a class="" href="lymphoid.html">Lymphoid</a></li>
<li><a class="" href="myeloid-neoplasia.html">Myeloid Neoplasia</a></li>
<li><a class="" href="aml.html">AML</a></li>
<li><a class="" href="myelodysplastic.html">Myelodysplastic</a></li>
<li><a class="" href="myeloproliferative.html">Myeloproliferative</a></li>
<li><a class="" href="lymphoid-neoplasia.html">Lymphoid Neoplasia</a></li>
<li><a class="" href="acute-lymphoid.html">Acute Lymphoid</a></li>
<li><a class="" href="chronic-b-cell.html">Chronic B-Cell</a></li>
<li><a class="" href="chronic-t-cell.html">Chronic T-Cell</a></li>
<li><a class="" href="plasma-cell.html">Plasma Cell</a></li>
<li><a class="" href="hereditary.html">Hereditary</a></li>
<li class="book-part">Platelets</li>
<li><a class="" href="plt-production.html">PLT Production</a></li>
<li><a class="" href="plt-function.html">PLT Function</a></li>
<li><a class="" href="plt-destruction.html">PLT Destruction</a></li>
<li><a class="" href="quantitative.html">Quantitative</a></li>
<li><a class="" href="thrombocytopenia-1.html">Thrombocytopenia</a></li>
<li><a class="" href="destruction.html">Destruction</a></li>
<li><a class="" href="production.html">Production</a></li>
<li><a class="" href="pseudo.html">Pseudo</a></li>
<li><a class="" href="thrombocytosis.html">Thrombocytosis</a></li>
<li><a class="" href="qualitative.html">Qualitative</a></li>
<li><a class="" href="von-willebrand.html">von Willebrand</a></li>
<li><a class="" href="bernard-soulier.html">Bernard-Soulier</a></li>
<li><a class="" href="glanzmann.html">Glanzmann</a></li>
<li class="book-part">Laboratory</li>
<li><a class="" href="cell-counts.html">Cell Counts</a></li>
<li><a class="" href="manual.html">Manual</a></li>
<li><a class="" href="automated.html">Automated</a></li>
<li><a class="" href="retics.html">Retics</a></li>
<li><a class="" href="differentials.html">Differentials</a></li>
<li><a class="" href="morphologies.html">Morphologies</a></li>
<li><a class="" href="hemoglobin.html">Hemoglobin</a></li>
<li><a class="" href="quantitative-1.html">Quantitative</a></li>
<li><a class="" href="qualitative-1.html">Qualitative</a></li>
<li><a class="" href="electrophoresis.html">Electrophoresis</a></li>
<li><a class="" href="hplc.html">HPLC</a></li>
<li><a class="" href="sickle-solubility.html">Sickle Solubility</a></li>
<li><a class="" href="hematocrit.html">Hematocrit</a></li>
<li><a class="" href="indices.html">Indices</a></li>
<li><a class="" href="hemolysis.html">Hemolysis</a></li>
<li><a class="" href="special-stains.html">Special Stains</a></li>
<li><a class="" href="other-studies.html">Other Studies</a></li>
<li><a class="" href="esr.html">ESR</a></li>
<li><a class="" href="g6pd.html">G6PD</a></li>
<li><a class="" href="heinz-body.html">Heinz Body</a></li>
<li><a class="" href="flow-cytometry.html">Flow Cytometry</a></li>
<li><a class="" href="leukemia.html">Leukemia</a></li>
<li><a class="" href="lymphoma.html">Lymphoma</a></li>
<li><a class="" href="lymphocyte-subsets.html">Lymphocyte Subsets</a></li>
<li><a class="" href="pnh.html">PNH</a></li>
<li><a class="" href="molecularcytogenetic.html">Molecular/Cytogenetic</a></li>
<li><a class="" href="recurring-abnormalities.html">Recurring Abnormalities</a></li>
<li><a class="" href="bcrabl1.html">BCR/ABL1</a></li>
<li><a class="" href="jak2.html">JAK2</a></li>
<li class="book-part">Hemostasis</li>
<li><a class="" href="coagulation-pathways.html">Coagulation Pathways</a></li>
<li><a class="" href="fibrinolytic-pathways.html">Fibrinolytic Pathways</a></li>
<li><a class="" href="vascular-system.html">Vascular System</a></li>
<li><a class="" href="disorders.html">Disorders</a></li>
<li><a class="" href="factor-deficiencies.html">Factor Deficiencies</a></li>
<li><a class="" href="hereditary-1.html">Hereditary</a></li>
<li><a class="" href="acquired.html">Acquired</a></li>
<li><a class="" href="inhibitors.html">Inhibitors</a></li>
<li><a class="" href="fibrinolytic.html">Fibrinolytic</a></li>
<li><a class="" href="thrombophilia.html">Thrombophilia</a></li>
<li><a class="" href="dic.html">DIC</a></li>
<li><a class="active" href="laboratory.html">Laboratory</a></li>
<li><a class="" href="ptinr.html">PT/INR</a></li>
<li><a class="" href="aptt.html">APTT</a></li>
<li><a class="" href="fibrinogen.html">Fibrinogen</a></li>
<li><a class="" href="d-dimer.html">D-dimer</a></li>
<li><a class="" href="thrombin-time.html">Thrombin Time</a></li>
<li><a class="" href="mixing-studies-1.html">Mixing Studies</a></li>
<li><a class="" href="factor-assays.html">Factor Assays</a></li>
<li><a class="" href="inhibitor-assays.html">Inhibitor Assays</a></li>
<li><a class="" href="von-willebrand-assays.html">von Willebrand Assays</a></li>
<li><a class="" href="platelet-function.html">Platelet Function</a></li>
<li><a class="" href="platelet-aggregation.html">Platelet Aggregation</a></li>
<li><a class="" href="thromboelastography.html">Thromboelastography</a></li>
<li><a class="" href="hypercoagulability.html">Hypercoagulability</a></li>
<li><a class="" href="assays.html">Assays</a></li>
<li><a class="" href="antiphospholipids.html">Antiphospholipids</a></li>
<li><a class="" href="protein-c.html">Protein C</a></li>
<li><a class="" href="protein-s.html">Protein S</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="fv-leiden.html">FV Leiden</a></li>
<li><a class="" href="pt-20210.html">PT 20210</a></li>
<li><a class="" href="anti-xa.html">Anti-Xa</a></li>
<li><a class="" href="thrombin-inhibitors.html">Thrombin Inhibitors</a></li>
<li><a class="" href="heparin-neutralization.html">Heparin Neutralization</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Microbiology/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="laboratory" class="section level1 unnumbered">
<h1>Laboratory<a class="anchor" aria-label="anchor" href="#laboratory"><i class="fas fa-link"></i></a>
</h1>
<div id="overview-of-the-testing-process" class="section level2 unnumbered">
<h2>
<strong>Overview of the Testing Process</strong><a class="anchor" aria-label="anchor" href="#overview-of-the-testing-process"><i class="fas fa-link"></i></a>
</h2>
<p>In clinical laboratories, the testing process is generally divided into three phases:</p>
<ul>
<li>
<strong>Pre-Analytical Phase:</strong> Includes all steps that occur <em>before</em> the actual testing of the sample. This is where most errors happen, so it is super important to know these steps!</li>
<li>
<strong>Analytical Phase:</strong> Includes the actual performance of the tests and quality control procedures</li>
<li>
<strong>Post-Analytical Phase:</strong> Includes the steps that occur <em>after</em> the tests have been performed, such as result review, interpretation, and reporting</li>
</ul>
</div>
<div id="pre-analytical-phase" class="section level2 unnumbered">
<h2>
<strong>Pre-Analytical Phase</strong><a class="anchor" aria-label="anchor" href="#pre-analytical-phase"><i class="fas fa-link"></i></a>
</h2>
<p>This phase encompasses all the steps that occur before the sample is analyzed, from test ordering to sample collection and transport. Errors in the pre-analytical phase are the most common source of errors in the laboratory and can significantly impact the accuracy and reliability of coagulation results</p>
<ul>
<li>
<strong>Test Ordering:</strong>
<ul>
<li>Appropriate Test Selection: Ensure that the correct coagulation tests are ordered based on the patient’s clinical presentation and the physician’s request
<ul>
<li>Common Coagulation Tests:
<ul>
<li>Prothrombin Time (PT) and International Normalized Ratio (INR)</li>
<li>Activated Partial Thromboplastin Time (aPTT)</li>
<li>Fibrinogen Level</li>
<li>D-dimer</li>
<li>Mixing Studies</li>
<li>Factor Assays (e.g., Factor VIII, Factor IX)</li>
<li>Lupus Anticoagulant Testing</li>
</ul>
</li>
</ul>
</li>
<li>Review Patient History: Check the patient’s medication list (especially anticoagulants) and history of bleeding or thrombotic disorders</li>
<li>Follow Laboratory Guidelines: Adhere to the laboratory’s test ordering policies and procedures</li>
</ul>
</li>
<li>
<strong>Patient Preparation:</strong>
<ul>
<li>Fasting: Some coagulation tests may require the patient to fast for a certain period of time</li>
<li>Medications: Certain medications (e.g., warfarin, heparin, direct oral anticoagulants) can affect coagulation test results and should be noted on the test requisition</li>
<li>Patient Identification: Properly identify the patient using two unique identifiers to prevent errors</li>
</ul>
</li>
<li>
<strong>Sample Collection:</strong>
<ul>
<li>Collection Tubes:
<ul>
<li>Use the correct type of blood collection tube:
<ul>
<li>Sodium Citrate (light blue top): The anticoagulant of choice for most coagulation tests</li>
<li>EDTA (purple top): Not appropriate for coagulation testing</li>
</ul>
</li>
<li>Check Expiration Date: Ensure that the collection tube is not expired</li>
</ul>
</li>
<li>Blood-to-Anticoagulant Ratio:
<ul>
<li>The correct blood-to-anticoagulant ratio is critical for accurate coagulation testing:
<ul>
<li>Typically 9:1 (9 parts blood to 1 part anticoagulant)</li>
</ul>
</li>
<li>Underfilling the tube can lead to falsely prolonged clotting times due to excess anticoagulant</li>
<li>Overfilling the tube can lead to falsely shortened clotting times due to insufficient anticoagulant</li>
<li>Adjust Blood-to-Anticoagulant Ratio in Patients with High Hematocrit: In patients with hematocrits &gt;55%, the amount of anticoagulant should be reduced to maintain the correct ratio</li>
<li>Use Vacutainer to fill to the line on the collection tube</li>
</ul>
</li>
<li>Order of Draw:
<ul>
<li>Follow the recommended order of draw to prevent contamination of coagulation samples:
<ol style="list-style-type: decimal">
<li>Blood culture tubes (if applicable)</li>
<li>Coagulation tube (light blue top)</li>
<li>Serum tubes (red top)</li>
<li>Heparin tubes (green top)</li>
<li>EDTA tubes (purple top)</li>
<li>Fluoride tubes (gray top)</li>
</ol>
</li>
</ul>
</li>
<li>Venipuncture Technique:
<ul>
<li>Perform a clean venipuncture to avoid tissue thromboplastin contamination</li>
<li>Avoid prolonged tourniquet time, as this can activate coagulation factors</li>
<li>Use a 21-gauge needle or larger to minimize hemolysis</li>
</ul>
</li>
<li>Mixing:
<ul>
<li>Gently invert the collection tube 5-10 times immediately after collection to mix the blood with the anticoagulant</li>
<li>Avoid vigorous shaking, as this can cause hemolysis</li>
</ul>
</li>
<li>Labeling:
<ul>
<li>Properly label the collection tube with the patient’s name, date and time of collection, and other required information</li>
<li>Ensure that the information on the tube matches the information on the test requisition</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Sample Transport and Storage:</strong>
<ul>
<li>Transport:
<ul>
<li>Transport the sample to the laboratory promptly (within 1 hour) to minimize pre-analytical changes</li>
<li>Transport at room temperature (18-24°C)</li>
<li>Avoid extreme temperatures (e.g., direct sunlight, freezing)</li>
</ul>
</li>
<li>Storage:
<ul>
<li>If testing cannot be performed immediately, store the sample according to the laboratory’s guidelines</li>
<li>Platelet Poor Plasma (PPP) may need to be prepared and frozen for some assays:
<ul>
<li>For most coagulation tests, plasma should be tested within 4 hours of collection or frozen for testing later. Specifics will vary from lab to lab.</li>
<li>Centrifuge the sample at 1500-2000 g for 15 minutes to obtain platelet-poor plasma (platelet count &lt; 10 x 10^9/L)</li>
<li>Aliquot the plasma into labeled plastic tubes</li>
<li>Freeze the plasma at -20°C or -70°C if needed to test at later date
<ul>
<li>Thaw samples to room temperature before testing</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="analytical-phase" class="section level2 unnumbered">
<h2>
<strong>Analytical Phase</strong><a class="anchor" aria-label="anchor" href="#analytical-phase"><i class="fas fa-link"></i></a>
</h2>
<p>This phase encompasses the actual testing of the sample and quality control procedures</p>
<ul>
<li>
<strong>Instrumentation:</strong>
<ul>
<li>Use Properly Calibrated Instruments: Ensure that coagulation analyzers are properly calibrated and maintained according to the manufacturer’s instructions</li>
<li>Use Correct Reagents: Verify that the reagents are appropriate for the test being performed and that they are not expired</li>
</ul>
</li>
<li>
<strong>Test Performance:</strong>
<ul>
<li>Follow Standard Operating Procedures: Adhere to standardized operating procedures (SOPs) for performing coagulation tests</li>
<li>Use Appropriate Controls: Run control materials at regular intervals (e.g., daily, with each batch of samples) to assess the accuracy and precision of the tests</li>
<li>Monitor Results: Review control results and evaluate them using statistical methods (e.g., Levey-Jennings charts, Westgard rules)</li>
<li>Take Corrective Action: If control results are outside the acceptable range, take corrective action before testing patient samples</li>
</ul>
</li>
<li>
<strong>Sample Handling:</strong>
<ul>
<li>Ensure that samples are properly identified and stored</li>
<li>Thaw frozen samples completely before testing and mix gently</li>
<li>Check for hemolysis, lipemia, or other interfering substances</li>
<li>If necessary, perform corrective actions to minimize interference (e.g., saline replacement for lipemia)</li>
</ul>
</li>
<li>
<strong>Common Test Specific Procedures</strong>
* Prothrombin Time (PT):
* Measures the function of the extrinsic and common pathways
* Add thromboplastin reagent to plasma and measure the time to clot formation
* Report results in seconds and as an International Normalized Ratio (INR) to standardize PT results
* INR = (Patient PT / Mean Normal PT)ISI (ISI = International Sensitivity Index)
* INR is used to monitor warfarin therapy
* Activated Partial Thromboplastin Time (aPTT):
* Measures the function of the intrinsic and common pathways
* Add a contact activator (e.g., silica, kaolin), phospholipid, and calcium chloride to plasma and measure the time to clot formation
* Used to monitor heparin therapy
* Fibrinogen Assay:
* Measures the concentration of fibrinogen in the plasma
* Clauss method: A functional assay that measures the rate of clot formation after the addition of thrombin
* D-Dimer Assay:
* Measures the level of D-dimer in the plasma
* Uses latex agglutination or immunoturbidimetric methods
* Elevated in conditions with increased fibrinolysis (e.g., DVT, PE, DIC)</li>
<li>
<strong>Monitoring and Troubleshooting:</strong>
<ul>
<li>Monitor Instrument Performance: Regularly monitor the instrument’s performance to detect any malfunctions or errors</li>
<li>Troubleshoot Problems: Follow established procedures for troubleshooting instrument errors or unexpected results</li>
<li>Consult with a Supervisor or Pathologist: Seek guidance from a supervisor or pathologist if the cause of the problem cannot be determined</li>
</ul>
</li>
</ul>
</div>
<div id="post-analytical-phase" class="section level2 unnumbered">
<h2>
<strong>Post-Analytical Phase</strong><a class="anchor" aria-label="anchor" href="#post-analytical-phase"><i class="fas fa-link"></i></a>
</h2>
<p>This phase encompasses the steps that occur after the tests have been performed, including result review, interpretation, and reporting</p>
<ul>
<li>
<strong>Result Review:</strong>
<ul>
<li>Review all test results and quality control data</li>
<li>Check for any flags, alarms, or abnormal results</li>
<li>Verify that the results are consistent with the patient’s clinical information and previous laboratory results</li>
</ul>
</li>
<li>
<strong>Result Interpretation:</strong>
<ul>
<li>Interpret the results in the context of the patient’s clinical history, medication list, and other laboratory findings</li>
<li>Consider potential causes for any abnormal results</li>
<li>Recognize patterns of results that are suggestive of specific coagulation disorders</li>
</ul>
</li>
<li>
<strong>Critical Value Notification:</strong>
<ul>
<li>Immediately notify the physician or other authorized personnel of any critical values (e.g., markedly prolonged PT or aPTT, very low fibrinogen level)</li>
<li>Follow the laboratory’s policy for critical value reporting</li>
</ul>
</li>
<li>
<strong>Reporting:</strong>
<ul>
<li>Report the test results in a clear, concise, and accurate manner</li>
<li>Include the reference range for each parameter</li>
<li>Note any interfering substances or corrective actions taken</li>
<li>Add interpretive comments to the report to guide the clinician’s interpretation of the results</li>
</ul>
</li>
<li>
<strong>Documentation:</strong>
<ul>
<li>Maintain accurate and complete records of all test results, quality control data, and corrective actions taken</li>
<li>Follow all regulatory and accreditation requirements for documentation</li>
</ul>
</li>
</ul>
</div>
<div id="key-terms-84" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-84"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>PT (Prothrombin Time):</strong> Test of the extrinsic and common pathways</li>
<li>
<strong>aPTT (Activated Partial Thromboplastin Time):</strong> Test of the intrinsic and common pathways</li>
<li>
<strong>INR (International Normalized Ratio):</strong> A standardized ratio of the PT used to monitor warfarin therapy</li>
<li>
<strong>Fibrinogen:</strong> A protein that is converted to fibrin, the main component of a blood clot</li>
<li>
<strong>D-dimer:</strong> A fibrin degradation product that is elevated in thrombotic conditions</li>
<li>
<strong>Pre-Analytical Phase:</strong> The steps that occur before the sample is analyzed</li>
<li>
<strong>Analytical Phase:</strong> The actual performance of the tests</li>
<li>
<strong>Post-Analytical Phase:</strong> The steps that occur after the tests have been performed</li>
<li>
<strong>Quality Control:</strong> Procedures used to monitor the accuracy and precision of laboratory testing</li>
<li>
<strong>Critical Value:</strong> A test result that represents a life-threatening condition and requires immediate notification</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  // adjust TOC scroll to selected element/topic
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    if(document.querySelector('.book-toc > li > a.active').offsetLeft == 0) {
      toc_element_position1 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetTop;
      toc_element_position2 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetHeight;
      toc_element_position = toc_element_position1 + toc_element_position2;
    }
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();

  // hide those labes that take up multiple lines
  l = [];
  function hide_label() {
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase"
          &&
          !elem.classList
          .contains('book-part')
          ? l.push(elem)
          : '';
      });
  }
  hide_label();
  head = document.getElementsByTagName('header')[0];
  head.addEventListener('scroll', () => {
    count = 0;
    prev_elem = '';
    l.forEach((elem) => {
      if(count === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_elem.classList.add('hide_label');
        } else {
          prev_elem.classList.remove('hide_label');
        }
      }
      prev_elem = elem;
    });
  });
</script><div class="chapter-nav">
<div class="prev"><a href="dic.html">DIC</a></div>
<div class="next"><a href="ptinr.html">PT/INR</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#laboratory">Laboratory</a></li>
<li><a class="nav-link" href="#overview-of-the-testing-process">Overview of the Testing Process</a></li>
<li><a class="nav-link" href="#pre-analytical-phase">Pre-Analytical Phase</a></li>
<li><a class="nav-link" href="#analytical-phase">Analytical Phase</a></li>
<li><a class="nav-link" href="#post-analytical-phase">Post-Analytical Phase</a></li>
<li><a class="nav-link" href="#key-terms-84">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Microbiology/blob/blob/main/Rmd/05-12-hemostasis-laboratory.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Microbiology/blob/edit/main/Rmd/05-12-hemostasis-laboratory.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
          <li><a id="buymeacoffee" href="https://buymeacoffee.com/bloodcellid" target="_blank">NEED Caffeine</a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-04-04 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
